EC
CRGX

EcoR1 Capital’s CARGO Therapeutics CRGX Stock Holding History

EcoR1 Capital’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,470,000
Closed -$21.2M – 49
2024
Q4 		$21.2M Hold
1,470,000
– – 0.8% 27
2024
Q3 		$27.1M Hold
1,470,000
– – 0.93% 26
2024
Q2 		$24.1M Buy
+1,470,000
New +$27.9M 0.74% 28

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $232M AUM 247.08% 1-Year Est. Return

EcoR1 Capital's CRGX Position: Q1 2025 in Review

EcoR1 Capital sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 1,470,000 shares — an estimated $21.2M sold.

EcoR1 Capital first reported a position in CRGX in Q2 2024 and held it in 3 quarters. The position peaked at $27.1M in Q3 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • EcoR1 Capital reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • EcoR1 Capital sold 1,470,000 CARGO Therapeutics shares in Q1 2025, an estimated $21.2M.
  • EcoR1 Capital first reported a position in CARGO Therapeutics in Q2 2024 and held it in 3 quarters.
  • EcoR1 Capital's CARGO Therapeutics position peaked at $27.1M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on EcoR1 Capital's 13F filing for Q1 2025, filed 15 May 2025.